The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients
Objective: The objective of this study is to compute the potential benefit of Pramipexole ER on total levodopa equivalent dose (LED) and Unified Parkinson Disease Rating Score (UPDRS-III) compared to mono- or combined therapy of pramipexole IR and/or carbidopa/levodopa.Methods: This is a retrospecti...
Guardat en:
| Publicat a: | Pharmacy Practice |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Centro de investigaciones y Publicaciones Farmacéuticas
2018
|
| Matèries: | |
| Accés en línia: | https://www.redalyc.org/articulo.oa?id=69060005003 https://www.redalyc.org/journal/690/69060005003/ https://www.redalyc.org/journal/690/69060005003/html/ https://www.redalyc.org/journal/690/69060005003/69060005003.epub https://www.redalyc.org/journal/690/69060005003/movil |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|